TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
Condition(s):Nonsmall Cell Lung Cancer; Solid Tumor, AdultLast Updated:February 14, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Nonsmall Cell Lung Cancer; Solid Tumor, AdultLast Updated:February 14, 2023Recruiting
Condition(s):Diffuse Large B-cell LymphomaLast Updated:November 7, 2023Recruiting
Condition(s):Acute Lymphoblastic Leukemia, Adult B-Cell; Acute Lymphoblastic Leukemia, in Relapse; Non-Hodgkin Lymphoma, B-cell; Diffuse Large B Cell Lymphoma; Central Nervous System Lymphoma; Lymphoma, Follicular; MCLLast Updated:January 23, 2024Not yet recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromeLast Updated:June 18, 2023Recruiting
Condition(s):T-cell Acute Lymphoblastic Lymphoma; T-non-Hodgkin LymphomaLast Updated:April 28, 2023Recruiting
Condition(s):Allogeneic Hematopoietic Stem Cell TransplantationLast Updated:February 6, 2024Recruiting
Condition(s):Lung Cancer; Cancer; Immunotherapy; CAR-T CellLast Updated:February 14, 2023Recruiting
Condition(s):Liver Cancer; Rhabdomyosarcoma; Malignant Rhabdoid Tumor; Liposarcoma; Wilms Tumor; Yolk Sac TumorLast Updated:February 5, 2024Not yet recruiting
Condition(s):B Cell MalignanciesLast Updated:June 29, 2022Recruiting
Condition(s):B Cell MalignanciesLast Updated:June 29, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.